What is the price target for AXNX stock?
19 analysts have analysed AXNX and the average price target is 73.33 USD. This implies a price increase of 3.31% is expected in the next year compared to the current price of 70.98.
Axonics Inc (AXNX) Forecast, Price Target & Analyst Ratings
NASDAQ:AXNX • US05465P1012
Current stock price
70.98 USD
+0.53 (+0.75%)
At close:
70.98 USD
0 (0%)
After Hours:
Analyst forecast overview
View the latest analyst price targets, stock forecast, EPS estimates, revenue projections, revisions, full estimates, rating distribution and upgrades/downgrades for Axonics Inc (AXNX).
Forecast Snapshot
Next Earnings Forecast
Earnings Estimate- Release Date
- N/A
- Period
- Q4 / 2024
- EPS Estimate
- $0.20
- Revenue Estimate
- 134.62M
Price Target Details & History
Consensus Price Target and Range
Mean target
$73.33
Upside
+ 3.31%
From current price of $70.98 to mean target of $73.33, Based on 19 analyst forecasts
Low
$71.71
Median
$72.42
High
$78.75
Price Target Revisions
1 Month
0.23%
3 Months
0.23%
Price Target Summary
19 Wall Street analysts provided a forecast for the next 12 months for AXNX. The average price target is 73.33 USD. This implies a price increase of 3.31% is expected in the next year compared to the current price of 70.98.
The average price target has been revised upward by 0.23% in the past 3 months.
Analyst Ratings & History
Current Analyst Ratings
Analyst Ratings History
Analyst Ratings Consensus
ChartMill Buy Consensus
68.42%
AXNX was analyzed by 19 analysts. The buy percentage consensus is at 68. So analysts seem to be have mildly positive about AXNX.
In the previous month the buy percentage consensus was at a similar level.
AXNX was analyzed by 19 analysts, which should be a sufficient number of analysts to have a meaningful average consensus rating.
Recent Upgrades & Downgrades
| Date | Firm | Action | From → To |
|---|---|---|---|
| 2024-11-08 | Needham | Reiterate | Hold |
| 2024-08-05 | Needham | Reiterate | Hold |
| 2024-05-06 | Needham | Reiterate | Hold |
| 2024-02-29 | RBC Capital | Reiterate | Sector Perform -> Sector Perform |
| 2024-01-17 | Needham | Downgrade | Buy -> Hold |
| 2024-01-16 | Truist Securities | Downgrade | Buy -> Hold |
| 2024-01-12 | Leerink Partners | Downgrade | Outperform -> Market Perform |
| 2024-01-12 | CL King | Downgrade | Buy -> Neutral |
| 2024-01-12 | Truist Securities | Downgrade | Buy -> Hold |
| 2024-01-12 | Piper Sandler | Downgrade | Overweight -> Neutral |
| 2024-01-10 | Wells Fargo | Downgrade | Overweight -> Equal-Weight |
| 2024-01-09 | Wolfe Research | Downgrade | Outperform -> Peer Perform |
| 2023-12-22 | Truist Securities | Maintains | Buy -> Buy |
| 2023-10-31 | Needham | Maintains | Buy -> Buy |
| 2023-10-31 | Morgan Stanley | Maintains | Overweight -> Overweight |
| 2023-10-31 | Piper Sandler | Maintains | Overweight -> Overweight |
| 2023-10-16 | Leerink Partners | Initiate | Outperform |
| 2023-07-28 | Needham | Maintains | Buy -> Buy |
| 2023-07-28 | Keybanc | Maintains | Overweight -> Overweight |
| 2023-07-28 | Baird | Maintains | Outperform -> Outperform |
| 2023-07-19 | Baird | Initiate | Outperform |
| 2023-07-14 | Mizuho | Reiterate | Buy -> Buy |
| 2023-07-13 | Keybanc | Initiate | Overweight |
| 2023-07-12 | RBC Capital | Maintains | Outperform -> Outperform |
| 2023-05-23 | CL King | Initiate | Buy |
Next Earnings Forecast Details
Next Earnings Details
- Release Date
- N/A
- Period
- Q4 / 2024
- EPS Estimate
- $0.20
- Revenue Estimate
- 134.62M
- Revenue Q2Q
- 22.68%
- EPS Q2Q
- 56.14%
- Number of Analysts
- 9
Next Earnings Revisions
Revenue (1 Month)
0.94%
Revenue (3 Months)
0.94%
EPS (1 Month)
21.53%
EPS (3 Months)
21.53%
Next Earnings Summary
The next earnings revenue estimate has been revised upward by 0.94% in the past 3 months.
Full Analyst Estimates
Yearly Earnings Per Share (EPS), Revenue, EBIT, EBITDA and Operating Margin Analyst Estimates
| 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | 180.3M 61.70% | 273.7M 51.80% | 366.379M 33.86% | 459.25M 25.35% | 550.73M 19.92% | 649.97M 18.02% | 765.76M 17.81% | 890.89M 16.34% | 1.051B 17.97% | 1.13B 7.52% | |
| EBITDA YoY % growth | -58.27M -11.93% | -30.58M 47.52% | 7.775M 125.43% | 77.495M 896.72% | 96.859M 24.99% | 114.78M 18.50% | 156.67M 36.50% | N/A | N/A | N/A | |
| EBIT YoY % growth | -67.4M -25.28% | -42.3M 37.24% | -4.712M 88.86% | -10.2K 99.78% | 32.886M 322,511.76% | 69.521M 111.40% | 102.36M 47.24% | 152.08M 48.57% | 204M 34.14% | 253.98M 24.50% | |
| Operating Margin | -37.38% | -15.45% | -1.29% | 0.00% | 5.97% | 10.70% | 13.37% | 17.07% | 19.41% | 22.48% | |
| EPS YoY % growth | -1.77 -18.00% | -1.30 26.55% | 0.18 113.85% | 0.28 56.54% | 0.87 209.50% | 1.45 65.89% | 1.93 33.61% | 2.52 30.34% | N/A | N/A |
All data in USD
Quarterly Earnings Per Share (EPS), Revenue, EBIT and EBITDA Analyst Estimates
| Q4 / 24 | Q1 / 25 | Q2 / 25 | Q3 / 25 | Q4 / 25 | |
|---|---|---|---|---|---|
| EPS Q2Q % growth | 0.20 56.14% | -0.05 80.73% | 0.19 42.54% | 0.17 | 0.25 21.27% |
| Revenue Q2Q % growth | 134.62M 22.68% | 113.17M 23.81% | 138.92M 21.26% | 140.81M 21.19% | 159.86M 18.75% |
| EBITDA Q2Q % growth | 26.316M 54.05% | 7.14M 158.67% | 29.104M 134.41% | 27.132M 317.16% | 31.212M 18.60% |
| EBIT Q2Q % growth | 7.065M 53.72% | -5.55M 63.85% | 8.629M 36.25% | 6.371M 328.02% | 10.529M 49.03% |
All data in USD
Yearly Earnings Per Share (EPS) and Revenue Trends vs Historical Data
Long Term Forward Growth Forecast Summary
Long Term EPS Growth (CAGR)
EPS Next 3 Year
100.31%
EPS Next 5 Year
69.51%
Long Term Revenue Growth (CAGR)
Revenue Next 3 Year
20.53%
Revenue Next 5 Year
19.14%
Long Term EBIT Growth (CAGR)
EBIT Next 3 Year
82.88%
EBIT Next 5 Year
66.14%
Axonics Inc / AXNX Forecast FAQ
Can you provide the consensus estimates for Axonics Inc next earnings?
The consensus EPS estimate for the next earnings of Axonics Inc (AXNX) is 0.2 USD and the consensus revenue estimate is 134.62M USD.
Can you provide the analyst count for Axonics Inc stock?
The number of analysts covering Axonics Inc (AXNX) is 19.